Nordic Issuing

Ongoing case

Cessatech A/S

Back to all cases

Cessatech A/S

25 Nov - 16 Dec 2021Warrant exercise

Cessatech A/S is a late-stage clinical company developing evidence-based treatment for children.

The lead asset (CT001) is an analgesic nasal spray for treatment of acute and planned painful procedures in children. The advantages include needle-free administration, being easy to administer, a fast-acting therapeutic effect and, when it has obtained regulatory approval, also being medically approved for children.

Read more on the company's website

The offer in summary

Exercise period:: November25th, 2021– December16th, 2021 3 p.m.

Subscription price:: DKK 10.00

Trading with warrants:: Until December 14th, 2021

About the warrant:: Each warrant of series TO 1 gives the holder the right to subscribe for one (1) new share

Payment day: : Payment and subscription form shall be Nordic Issuing at handnolater than 3 p.m. December16th, 2021.





Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.